Niagen Bioscience (NAGE) Q2 Earnings and Revenues Surpass Estimates
Niagen Bioscience (NAGE) delivered earnings and revenue surprises of +100.00% and +8.99%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?